Key result
RSAD1 impairs picornavirus replication by oxidizing and degrading viral polymerase, a process MSRB3 reverses.
Why the study?
Picornaviruses are important pathogens that cause fever, herpes, and myocarditis, but the interplay between picornaviruses and their hosts remains enigmatic.
RSAD1-MSRB3-mediated redox cycling of 3D polymerase regulates picornavirus infection, revealing a host antiviral mechanism and potential therapeutic target.
May identify host redox targets for picornavirus antivirals; leaves open translation from animal models to clinical use.
Picornaviruses, including foot-and-mouth disease virus (FMDV), enterovirus 71 (EV71) and encephalomyocarditis virus (EMCV), are important pathogens that cause fever, herpes, and myocarditis in humans and animals. The interplay between picornaviruses and their hosts remains enigmatic. Here we perform porcine genome-wide CRISPR/Cas9 screens and identify methionine sulfoxide reductase B3 (MSRB3) as an essential factor for FMDV. MSRB3 deficiency inhibits FMDV replication. Mechanistically, MSRB3 eliminates methionine oxidation of FMDV 3D polymerase and stabilizes its expression. Further studies show that radical SAM domain-containing protein 1 (RSAD1) catalyzes methionine oxidation of FMDV 3D polymerase and promotes its aggregation and subsequent degradation through the autophagy-lysosome pathway. Importantly, RSAD1-MSRB3-mediated redox modification also affects the stability of 3D polymerases of EV71 and EMCV, and regulates their infectivity and pathogenesis both in vitro and in vivo. Collectively, this study corroborates that RSAD1-MSRB3-mediated redox cycling of 3D polymerase plays a conserved function in modulating picornavirus infection, providing insights into viral pathogenesis and broad-spectrum antiviral development. Li et al. demonstrate that RSAD1-MSRB3-mediated redox cycling of 3D polymerase plays a conserved function in regulating picornavirus infection, facilitating the elucidation of viral pathogenesis and development of broad-spectrum antiviral therapies.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied Picornavirus infection (FMDV, EV71, EMCV). MSRB3 and RSAD1 genetic manipulation vs. Control cells/mice was evaluated on Viral replication (viral RNA, protein levels, progeny virus titer). RSAD1 catalyzes methionine oxidation of viral 3D polymerase to promote its degradation and impair picornavirus replication, while MSRB3 eliminates this oxidation to stabilize the polymerase.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: